A comparative trial of subcutaneous terbutaline, Th1165a and adrenaline in bronchial asthma.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004837:Epinephrine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D009921:Metaproterenol / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D010636:Phenols / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D012123:Pulmonary Ventilation / Q000187:drug effects; D013726:Terbutaline / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
D001993:Bronchodilator Agents; D010636:Phenols; D009921:Metaproterenol; D013726:Terbutaline; D004837:Epinephrine